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ABSTRACT
Conflicts between replication and transcription chal-
lenge chromosome duplication. Escherichia coli
replisome movement along transcribed DNA is pro-
moted by Rep and UvrD accessory helicases with
rep uvrD cells being inviable under rapid growth
conditions. We have discovered that mutations in
a tRNA gene, aspT, in an aminoacyl tRNA syn-
thetase, AspRS, and in a translation factor needed
for efficient proline–proline bond formation, EF-P,
suppress rep uvrD lethality. Thus replication-
transcription conflicts can be alleviated by the partial
sacrifice of a mechanism that reduces replicative bar-
riers, namely translating ribosomes that reduce RNA
polymerase backtracking. Suppression depends on
RelA-directed synthesis of (p)ppGpp, a signalling
molecule that reduces replication-transcription con-
flicts, with RelA activation requiring ribosomal paus-
ing. Levels of (p)ppGpp in these suppressors also
correlate inversely with the need for Rho activ-
ity, an RNA translocase that can bind to emerging
transcripts and displace transcription complexes.
These data illustrate the fine balance between differ-
ent mechanisms in facilitating gene expression and
genome duplication and demonstrate that accessory
helicases are a major determinant of this balance.
This balance is also critical for other aspects of bac-
terial survival: the mutations identified here increase
persistence indicating that similar mutations could
arise in naturally occurring bacterial populations fac-
ing antibiotic challenge.
INTRODUCTION
Cell survival from one generation to the next relies on effi-
cient and faithful replication of the genome. However, the
template for replication frequently harbours obstacles that
have the potential to interfere with the progression of repli-
some complexes, the macromolecular machines responsible
for driving genome duplication. Protein–DNA complexes
are important sources of such obstacles and those associ-
ated with transcription are especially problematic, in part
because of their abundance and in part because they present
multiple different challenges to replisome movement (1,2).
One major challenge is the very high free energy of bind-
ing of transcription complexes that creates a need to disrupt
many RNA polymerase–nucleic acid interactions as repli-
cation proceeds. Transcribing RNA polymerases (RNAPs)
also pause frequently either spontaneously or upon encoun-
tering DNA template damage (3). Paused RNAPs can also
diffuse backwards along the template resulting in displace-
ment of the transcript 3′ end from the RNAP active site.
This causes an inability to resume transcription, creating
barriers to replication that threaten genome stability (4,5).
Mechanisms exist that reduce the probability of a repli-
cation fork encountering paused transcription complexes.
Upstream RNAPs on the DNA and ribosomes on the
emerging transcript may inhibit backtracking of a paused
transcription complex in bacteria (5–7). RNA translocases
such as the bacterial Rho hexamer can also translocate
along transcripts not coated with ribosomes and displace
paused and blocked RNAPs (5,8,9). Rho translocation also
disrupts R-loops, structures in which an RNA transcript
hybridizes to the DNA template strand (9). Nucleases can
also aid genome duplication by promoting the resumption
of transcription by backtracked RNAP (5,10). GreA and
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GreB bind to E. coliRNAP and stimulate cleavage of back-
tracked transcripts, creating a new RNA 3′ end that can be
used to restart transcription (11). Conversely, the 3′-5′ heli-
case UvrD can increase rather than decrease backtracking
of RNAP and this may increase access of nucleotide exci-
sion repair enzymes UvrABC toDNAdamage thus helping
to clear barriers to RNAP and aid genome duplication (12).
Signalling molecules such as guanosine tetraphosphate
and pentaphosphate in bacteria (referred to collectively as
(p)ppGpp) can also reprogramme transcription. (p)ppGpp
is central to the stringent response in bacteria, identi-
fied originally as a response to amino acid starvation in
which the presence of uncharged tRNA within the riboso-
mal A site stimulates ribosome-bound RelA to synthesize
(p)ppGpp (13–15). Control of the stringent response also
requires a (p)ppGpp-specific pyrophosphohydrolase, SpoT,
that also has low (p)ppGpp synthase activity (15). However,
the synthase activity of SpoT is induced by other stresses
such as depletion of fatty acids (16). Central to the stringent
response is binding of (p)ppGpp to RNAP which leads to
downregulation of stable RNA production and upregula-
tion of stress response genes (15,17,18). Expression of ribo-
somal rRNA operons accounts for half of all transcription
during rapid growth when (p)ppGpp levels are low and thus
provides the majority of transcriptional obstacles to repli-
somes in vivo when cells are dividing quickly (19–22). Ele-
vated (p)ppGpp therefore reduces conflicts between repli-
cation and transcription by decreasing the density of tran-
scribing RNAPs on the genome. (p)ppGpp can also de-
crease the stability of transcription complexes blocked by
template damage in vitro which may decrease the density
of blocked RNAP on the genome (10). This destabiliza-
tion has been questioned, though, and a role for (p)ppGpp
in increasing the fidelity of transcription and hence reduc-
ing RNAP pausing and backtracking has been proposed
(23). Other work implicates (p)ppGpp acting synergistically
with UvrD in promoting backtracking of paused RNAP,
one function of which could be to facilitate transcription-
coupled repair of any pause-inducing DNA damage (24).
Thus, how (p)ppGpp might act on transcription elongation
complexes, as opposed to transcription initiation, is still far
from clear. Transcription is not the only target of (p)ppGpp,
though, since (p)ppGpp also binds multiple other targets.
Inhibited targets include DnaG primase (25–28) and the
translation elongation factors EFG and EF-Tu (29), in-
dicating the pleiotropic impact of elevated (p)ppGpp on
replication, transcription and elongation. (p)ppGpp also
affects other diverse aspects of metabolism such as phos-
pholipid synthesis, oxidative metabolism and resistance to
antibiotics (30). These signalling molecules also enhance
the ability of E. coli to persist in the presence of antibi-
otics. Persistence is the non-heritable ability of a small frac-
tion of a bacterial population to survive exposure to an
otherwise lethal concentration of antibiotic (31). (p)ppGpp
levels vary stochastically in a bacterial population and in-
creased (p)ppGpp activates toxin–antitoxin systems that in-
duce slow growth in a sub-population of cells, leading to
antibiotic tolerance (32).
Mechanisms also exist to increase the probability of con-
tinued replisome movement in the event of a collision with
an RNAP. Accessory replicative motors provide a supply of
additional helicases at the fork to aid protein displacement
ahead of the replisome (33–37). In E. coli Rep helicase pro-
motes movement of replisomes along protein-bound DNA
in vitro and in vivo (20,34). Rep appears to be the main repli-
some anti-pausing factor in E. coli (38) and absence of Rep
results in at least a two-fold increase in genome duplica-
tion time (39,40) and higher dependence on recombination-
directed repair of damaged forks (41–44). However, rep
cells remain viable since the homologous helicase UvrD can
substitute for the absence of Rep at the replication fork
(20,34). This substitution is only partial, though, and cor-
relates with a physical and functional interaction between
DnaB and Rep but not between DnaB and UvrD (34,45).
This partial functional overlap is sufficient for single dele-
tionmutants to be viable during rapid growth whereasrep
uvrD cells are not (46). rep uvrD inviability can be
suppressed by growth on minimal medium, conditions un-
der which (p)ppGpp levels are high, and also by eleva-
tion of (p)ppGpp levels on rich medium via the spoT1 mu-
tation encoding a (p)ppGpp pyrophosphorylase-defective
SpoT (20,34). Mutations within rpo genes can also suppress
rep uvrD rich medium lethality (20,34,47). These mu-
tant RNAPs display different phenotypes suggesting dis-
tinct mechanisms of suppression but some seem to pheno-
copy elevated (p)ppGpp and/or reduce RNAP backtrack-
ing (10,47,48).
The above mechanisms reduce conflicts between repli-
cation and transcription but under rapid growth condi-
tions forks are still blocked sufficiently frequently to re-
quire replisome reloading enzymes to maintain viability
(49,50). Replisome reloading also often requires remodel-
ing of the DNA at the blocked fork by recombination en-
zymes in order to generate a DNA structure suitable for
replisome reloading (51). However, recombinational pro-
cessing can lead to genome instability and is thus tightly
controlled. One control is exerted by UvrD as it can disrupt
RecA-ssDNA filaments and this disruption prevents exces-
sive RecFOR-dependent loading of RecA onto ssDNA at
blocked forks (52). Such excessiveRecA loading contributes
to rep uvrD lethality, evinced by the weak suppression
of repuvrD rich medium lethality via mutations in recF,
recO or recR (34,53,54).
We have searched for suppressors of rep uvrD rich
medium lethality that are not within rpo, spoT, recF, O
or R. We identified a spontaneous suppressor in a tRNA
gene, aspT[t8c], that mutated a highly conserved residue
that is structurally important in other tRNA species. Prob-
ing the basis of this suppression revealed that defective
tRNA aminoacylation or inefficient peptide bond forma-
tion within the ribosome also suppressed rep uvrD
lethality. In all cases, suppression required RelA-directed
(p)ppGpp synthesis indicating that stalling of ribosome
translocation by uncharged tRNA in the A site of ribo-
somes underpinned suppression. Thus, although efficient
translation elongation aids genome duplication (5,7), the
partial inhibition of ribosome translocation is more effec-
tive at mitigating replication-transcription conflicts. These
data illustrate the fine balance between the multiple mech-
anisms that promote simultaneous gene expression and
genome duplication and reveal the importance of accessory
replicative helicase activity in determining this balance.
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MATERIALS AND METHODS
Plasmids and strains
pAM403 (55) and pAM407 (34) are pRC7 derivatives
encoding rep and uvrD, respectively. p3LC-TL30-5P and
p3LC-TL30-5D contain a cadC–lacZ gene fusion in which
five tandem codons present within the linker encode proline
or aspartate, respectively (56). Strains were constructed by
P1 vir transduction and are listed in Supplementary Table
S1.
Genome sequencing and analysis
DNA was extracted from 1 culture each of strain N7153
and N7182 grown in LB broth to stationary phase us-
ing Qiagen 100/G genomic tips from 5 ml cultures fol-
lowing the manufacturer’s protocol. Genome sequencing
was performed using an Illumina GAIIx instrument with
100 bp paired end reads. Paired reads were trimmed to
remove adapters and mapped against the E. coli K12
strain MG1655 NC 000913 genome using bwa (57), du-
plicates marked using Picard (http://broadinstitute.github.
io/picard) and variant analysis performed with SAMtools
(58), followed by merging of variant tables using perl. Iden-
tified high quality synonymous and non-synonymous sin-
gle nucleotide polymorphisms were annotated manually us-
ing the Integrative Genomics Viewer (59). The Illumina
data were submitted in the form of fastq files to the Euro-
peanNucleotide Archive (ENA) and are available under ac-
cession number PRJEB14483 at http://www.ebi.ac.uk/ena/
data/view/PRJEB14483.
Growth assays
All steps in plasmid loss assays were carried out at 37◦C
except those shown in Figures 2B and 3B in which all steps
were conducted at 30◦C or 25◦C as indicated. Colonies were
grown in LB broth and agar except the assays in Figure 2B
and Supplementary Figures S3B and S4 which were per-
formed with a defined rich medium broth and agar contain-
ing 0.2% glycerol (Figure 2B) or 0.2% glucose (Supplemen-
tary Figures S3B and S4) as a carbon source (60). The plates
used in Supplementary Figures S3B and S4 also had de-
creasing concentrations of aspartate or phenylalanine, as in-
dicated. Strains carrying derivatives of pRC7 were grown in
LB broth or defined richmediumwith 100gml−1 of ampi-
cillin overnight, diluted 100-fold into the same type of fresh
liquid medium without ampicillin and grown to A650 0.4.
Dilutions were then plated onto LB or defined rich medium
agar plates containing 120 g ml−1 X-gal and 1 mM IPTG
and incubated for 48 h except those shown in Figure 2B.
Plates were then photographed and scored for blue/white
colony formation.
For assays to assess colony forming ability, strains were
grown in LB broth overnight at 37◦C or, when tempera-
ture sensitive strains were involved, at 30◦C. Serial 10-fold
dilutions were made with 56/2 salts (61) on ice and then
5 l of each dilution was spotted onto LB agar plates.
Plates were then incubated at 37◦C for 16 h unless other-
wise stated. Ampicillin and bicyclomycin were included in
LB agar plates where indicated at 100 and 25 g ml−1, re-
spectively.
For the colony formation assays in SupplementaryFigure
S3A, strains were grown in defined rich medium broth (60)
containing 0.2% glucose, all amino acids and 100 g ml−1
ampicillin overnight at 37◦C. Tenfold serial dilutions were
made in 56/2 salts and then 5 l of each dilution spotted
onto defined rich medium plates containing 0.2% glucose,
100 g ml−1 ampicillin and with all amino acids or missing
either aspartate or phenylalanine. These plates were incu-
bated at 37◦C for 16 h. Minimal medium agar plates (61)
were used in Supplementary Figure S3C without and with
100 g ml−1 ampicillin as indicated and incubated at 37◦C
for 72 h.
Colony-forming ability at increasing doses of UV light
was assessed as described (62). Mismatch repair capacity
was measured as the fraction of cells in a culture that ac-
quired spontaneous mutations leading to rifampicin resis-
tance. Briefly, overnight LB cultures were washed once in
56/2 salts and serially diluted 10-fold. 100 l of the neat
and the 10−1 dilution were spread on LB agar containing
15 g ml−1 rifampicin. To estimate the total cfu ml−1 in the
overnight culture, 10 l of the 10−6 dilution was spotted in
triplicate on LB agar without rifampicin. Plates were then
incubated at 37◦C for 16 h and the colonies then counted.
The liquid growth assays in Figure 2A were performed
using a Tecan InfiniteM200 Pro plate reader. Overnight LB
cultures were diluted toA600 0.005 in LB and 150 l of each
culture was transferred into 20 wells of a 96-well flat bottom
plate (Corning). The microplate was incubated at 37◦C for
24 h and A600 measurements were performed every 30 min
preceded by plate shaking.
Persistence
Single colonies were inoculated into 5 ml LB broth and
grown with shaking at 37◦C overnight. 50 l of overnight
culture was then inoculated into 5 ml of LB broth and
grown at 37◦C with shaking until 1–2 × 108 colony form-
ing units ml−1 reached. 500 l was then transferred into two
1.5 ml microcentrifuge tubes. The first tube was centrifuged
at 6000 rpm for 5 min at room temperature, resuspended in
500 l 56/2 salts, serially diluted tenfold in 56/2 salts and
10 l volumes of the 10−4 and 10−5 dilutions spotted onto
LB agar plates containing 20 mM MgSO4 in triplicate. To
the second tube 5 l of 10 g ml−1 ciprofloxacin was added
and the tube was then inserted into a 50 ml Falcon tube and
placed in a shaking incubator at 37◦C for 5 h. After the 5
h incubation, this tube was centrifuged at 6000 rpm for 5
min at room temperature, resuspended in 500 l 56/2 salts,
recentrifuged and resuspended in 500 l 56/2 salts. Colony-
forming units were then assayed as for the first tube by se-
rial dilution into 56/2 salts and plating in triplicate onto
LB agar containing 20 mM MgSO4. MgSO4 was included
to inhibit the activity of any traces of ciprofloxacin not re-
moved bywashing of the cells (63). All plateswere incubated
at 37◦C overnight and then the fraction of colony forming
units surviving ciprofloxacin exposure calculated.
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Flow cytometry
Analysis of chromosome content after completion of all
ongoing rounds of replication, so-called run-out condi-
tions, was performed on mid-log phase cultures after treat-
ment with rifampicin and cephalexin as described (64) us-
ing a Becton Coulter CyAn ADP cytometer with 488 nm
excitation and a 530/540 nm bandpass filter. Analysis of
(p)ppGpp-dependent formation of RpoS-mCherry by flow
cytometry was performed by growing the indicated strains
overnight in LB, transferring 100 l into 10 ml LB in a 125
ml flask followed by incubation at 37◦C for 2 h. Then 1ml of
the culture was centrifuged, resuspended in 2 ml of 10% LB
inM9medium and analysed by flow cytometry on a Becton
Dickinson LSRFortessa X-20 flow cytometer using 561 nm
laser excitation and dection using a 610/620 nm bandpass
filter.
Translation assays
-Galactosidase activity assays monitoring the relative lev-
els of translation of cadC–lacZ fusions were performed in
LB broth as described (56).
RESULTS
A tRNA mutation suppresses the requirement for accessory
replicative helicases
pRC7 is a very low copy plasmid which encodes  lacta-
mase and can therefore be maintained in E. coli cells by
the inclusion of ampicillin in the medium (65). However,
the inefficient origin of replication within pRC7 results in
rapid loss of the plasmid in the absence of ampicillin. This
rapid loss can be detected if the host strain has a chro-
mosomal deletion of lacIZYA since pRC7 encodes the lac
operon and hence cells with and without the plasmid ap-
pear blue andwhite, respectively, on plates containing IPTG
and X-gal (65). This retention or loss of pRC7 can be used
to assess whether a gene is essential for colony formation
by cloning of the test gene into pRC7, transformation of a
lacIZYA strain with the pRC7 derivative and subsequent
deletion of the test gene from the chromosome. Plating of
the strain onto medium containing IPTG and X-gal results
in formation of only blue colonies if the test gene is essen-
tial or white and segregating colonies if the test gene is not
essential (65). Rapid growth of E. coli requires accessory
helicase activity and so pRC7 encoding uvrD can be lost
rapidly from lacIZYA rep+ uvrD+ cells on rich medium
but pRC7uvrD cannot be lost from lacIZYArepuvrD
cells as monitored by blue/white colony colour (34) (see
also Figure 1A, compare i and ii). Spontaneous mutations
that suppress this requirement for an accessory helicase can
be isolated by exploiting the ability of rep uvrD cells to
grow on minimal medium in the absence of a complement-
ing pRC7 plasmid and subsequent plating of plasmid-less
cells onto rich medium (34). Rare survivors on rich medium
can then form colonies and the mutation(s) responsible for
allowingrepuvrD cells to grow under rapid growth con-
ditions can be analysed. We identified one such suppres-
sor, the strain designation of which is N7182 (Supplemen-
tary Table S1). Potential linkage of the suppressor mutation
to rep was tested by transducing rep::cat from the sup-
pressor strain into pRC7uvrD/rep+ ΔuvrD::dhfr (N6639).
Eleven chloramphenicol-resistant transductants were tested
for loss of pRC7uvrD on rich medium. Four transductants
could not lose pRC7uvrD but seven could, indicating close
linkage of the suppressor mutation with rep::cat (see also
Figure 1A, compare ii and iii).
We sequenced the genome of this suppressor strain and
compared it with the genome of N7153, a rep uvrD
strain that contains a well-characterized suppressor muta-
tion rpoB*35 (5,10,34,66). Use of the rep uvrD rpoB*35
strain as a reference genome avoided the need for the refer-
ence strain to retain a complementing plasmid for viabil-
ity. Only one mutation in N7182 that was not present in
N7153 was located sufficiently close to rep::cat to explain
the above linkage (see Supplementary File 1). Thismutation
resulted in replacement of T with C at position 8 within the
aspT gene, one of three identical tRNAAsp genes in E. coli.
Sequencing of the aspT gene from the 11 transductants ob-
tained in the above cross revealed that all seven strains able
to lose pRC7uvrD contained aspT[t8c] whereas all four
that could not lose pRC7uvrD retained a wild type copy of
aspT. Suppression of the inviability of repuvrD cells on
rich medium was therefore associated with the aspT[t8c]
allele, with suppression comparable to that of rpoB*35 in a
plasmid loss assay (Figure 1A, compare iii and iv).
rep uvrD+ cells have a growth defect defect since UvrD
can compensate only partially for the absence of Rep ac-
cessory helicase activity, resulting in slower movement of
replication forks in rep cells (39,40). Thus, the median
number of copies of oriC in rep uvrD+ cells is twice that
of rep+ uvrD+ cells in rich medium due to an extended
cell cycle in rep cells and hence more replication initia-
tion events per cell cycle (38). This doubling in oriC num-
bers results in a doubling of chromosome content when
cells are treated with cephalexin and rifampicin to inhibit
cell division and reinitiation of replication, so-called run-
out conditions (38) (see also Figure 1B, compare i and
iii). aspT[t8c] suppressed the increased chromosome copy
number in rep uvrD+ cells, reducing the median number
of chromosomes from eight to four (Figure 1B, compare iii
and iv). These data support the conclusion that this tRNA
mutation reduces the need for accessory helicase activity.
Furthermore, aspT[t8c] had no detectable impact on other
UvrD-mediated processes. Defects in nucleotide excision re-
pair, mismatch repair and control of recombination in rep+
uvrD cells (52,67,68) were not suppressed by aspT[t8c]
(Supplementary Figure S1A, B andC, respectively), provid-
ing further support for the specific suppression of the acces-
sory helicase defect in rep uvrD cells by aspT[t8c].
The requirement for accessory helicase activity is driven
primarily by transcriptional barriers to replication (20,34).
Backtracking of paused RNA polymerases results in for-
mation of particularly stable replicative barriers and mul-
tiple factors have evolved to reduce the numbers of
backtracked complexes (5). Cells lacking two homolo-
gous anti-backtracking factors, GreA and GreB, display
a temperature-sensitive growth defect that is a conse-
quence of more frequent collisions between replisomes and
backtracked transcription complexes (5,10,69). aspT[t8c]
suppressed the temperature-sensitive phenotype of greA
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Figure 1. Amutation in an aspartyl tRNA gene suppresses the need for accessory replicative helicases and for anti-backtracking factors. (A) Retention or
loss of pRC7uvrD (pAM407) from strains without or with rep uvrD deletions as judged by blue/white colony color on LB plates containing X-gal and
IPTG. Fractions of white colonies are indicated below each image with actual numbers of white versus total colonies counted in parentheses. (B) DNA
content of the indicated strains as monitored by flow cytometry under run out conditions in LB. The number of chromosome equivalents per cell is shown
below. (C) The viability of greA+ greB+ versus greA greB cells without and with aspT[t8c] as monitored by serial dilutions of liquid cultures grown at
30◦C and plated subsequently on LB agar at 30◦C and 42◦C.
greB cells (Figure 1C), similar to the suppression seen
with rpoB*35 (48). We conclude that aspT[t8c] reduces
the need for GreA/GreB-dependent rescue of backtracked
RNA polymerase.
Taken together, these data indicate that aspT[t8c] re-
duces the need for Rep and UvrD to underpin replication
and for anti-backtracking factors to resuscitate transcrip-
tion complexes.
Suppression by aspT[t8c] does not occur via growth rate re-
striction
The uridine encoded at position 8 within the wild type aspT
gene is post-transcriptionally modified to 4-thiouridine and
this modified nucleotide is conserved across all kingdoms
of life (70). This residue is involved in a triple non-Watson–
Crick pairing interaction and is important in coordination
of magnesium within tRNA (71,72). This central structural
role is reflected in the temperature-dependent destabilisa-
tion of human mitochondrial tRNAMet structure by the
same T to C mutation as found in aspT[t8c]. This transi-
tion mutation in tRNAMet inhibits aminoacylation and any
mutated tRNAMet that is aminoacylated fails to form a sta-
ble ternary complex with elongation factor EF-Tu (70).
Given the conservation of tRNA structure, aspT[t8c]
may result in similar structural destabilisation of the en-
coded tRNAAsp and consequent inhibition of interac-
tions with aspartyl tRNA synthetase and EF-Tu. However,
aspT[t8c] did not have a major impact on growth of rep+
uvrD+ cells in liquid culture (Figure 2A, compare i and ii).
This absence of a significant growth defect in aspT[t8c]
strains may be due to the presence of two other identical
tRNAAsp genes in E. coli, aspU and aspV.
Other means of growth restriction did not suppress rep
uvrD inviability. Growth on defined rich medium contain-
ing all 20 amino acids but with a poor carbon source, glyc-
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Figure 2. The impact of aspT[t8c] on growth and its relevance to rep
uvrD inviability. (A) Growth of (i) aspT+efp+ (TB28), (ii) aspT[t8c] efp+
(KM231) and (iii) aspT+ efp (MH299) in LB at 37◦C asmonitored by ab-
sorbance at 600 nm. (B) Assessment of the ability of pRC7uvrD (pAM407)
to be lost from rep uvrD cells by reducing growth rates via culturing at
37◦C and 25◦C for the indicated times on defined rich medium containing
glycerol as a carbon source.
erol, did not result in suppression of repuvrD aspT+ in-
viability at either 37◦C or 25◦C as determined using a plas-
mid loss assay (Figure 2B). Reduced growth rates therefore
do not provide a general means of reducing the need for ac-
cessory helicase activity.
Defective tRNA aminoacylation suppresses rep uvrD in-
viability
As reduced growth rate was not the cause of suppression by
aspT[t8c], we probed whether defective translation was re-
sponsible. We could not detect significant defects in trans-
lation in vivo at tandem aspartate codons in an aspT[t8c]
strain (Supplementary Figure S2). Either this allele does not
result in translational pausing or such pausing is below the
limits of detection using this assay. We therefore used al-
ternative approaches to probe the aspT[t8c] suppression
mechanism. The same t8c mutation in human mitochon-
drial tRNAMet inhibits aminoacylation (70). Inhibition of
tRNAAsp aminoacylation was therefore tested for suppres-
sion of rep uvrD lethality. The E. coli tls-1 allele en-
codes a P555S mutation in aspartyl tRNA synthetase that
reduces the thermal stability of the synthetase and causes a
severe reduction in growth rate at 42◦C under low salt con-
ditions (73,74) (see also Figure 3A). Given that AspRSP555S
is less stable than wild type enzyme regardless of the tem-
perature (74), we tested whether aspSP555S suppressed rep
uvrD lethality at 30◦C on low salt medium, conditions un-
der which viability is similar to wild type (73) (see also Fig-
ure 3A, compare i and ii). pRC7uvrD could be lost from
rep uvrD aspSP555S at 30◦C on low salt medium but not
on high salt medium (Figure 3Biii). Suppression of rep
uvrD lethality correlates therefore with a defect in aspartyl
tRNA synthetase.
We also tested whether an alternative means of inhibiting
tRNAAsp aminoacylation could suppress rep uvrD invi-
ability. A pRC7uvrD/repuvrD strain defective in aspar-
tate biosynthesis could lose the complementing pRC7uvrD
plasmid on defined rich medium upon restriction of aspar-
tate availability (Supplementary Figure S3). Thus a defect
in the enzyme needed to synthesize aspartyl tRNA, AspRS,
or a limiting concentration of one of the substrates needed
for formation of aspartyl tRNA, aspartate, can suppress the
need for accessory replicative helicase activity. Moreover,
suppression was not specific to aspartate starvation as re-
striction of availability of phenylalanine also allowed rep
uvrD cells to survive in the absence of a complementing
plasmid (Supplementary Figure S4). As expected, restrict-
ing amino acid availability also resulted in very poor growth
(Supplementary Figures S3 and S4) but a restricted growth
rate does not by itself provide suppression of rep uvrD
lethality (Figure 2B). These data support the conclusion
that inhibition of aminoacylation of tRNAAsp, and of other
tRNAs, reduces the need for accessory helicase activity.
Translational pausing suppresses rep uvrD inviability
Suppression of rep uvrD inviability via inhibition of
tRNAAsp or tRNAPhe aminoacylation might occur directly
via pausing of ribosomes but could also occur via decreased
production of one ormore specific proteins containing both
aspartate and phenylalanine. We tested therefore whether
increased translational pausing by a well-defined mecha-
nism that does not rely on decreased tRNA aminoacyla-
tion also suppresses the need for accessory helicase activ-
ity. Peptide bond formation by ribosomes occurs with low
efficiency within polyproline tracts as compared with other
amino acids and this low efficiency is compensated for by
interaction of elongation factor P (EF-P) with the ribo-
some (56,75). When EF-P is absent (efp) ribosomes pause
for extended periods at tandem proline codons (56,75) (see
also Supplementary Figure S2) resulting in reduced growth
rates (76) (see also Figure 2A). Despite its negative effect on
growth rate, introduction of efp clearly suppressed rep
uvrD lethality (Figure 4, compareA andB). yjeA and yjeK
encode enzymes needed for post-translational modification
of EF-P to form functional enzyme (56,75–78) and deletion
of either yjeA or yjeK also resulted in suppression (Figure
4C and D). Enhancement of ribosomal pausing at polypro-
line sequences can therefore reduce the need for accessory
helicase activity.
Suppression by aspT[t8c] and efp requires (p)ppGpp syn-
thesis
One consequence of ribosomal pausing is increased synthe-
sis of (p)ppGpp by RelA upon binding of RelA to a ribo-
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Figure 3. Amutation in aspartyl tRNA synthetase suppresses repuvrD lethality. (A) The indicated strains were grown overnight in high salt medium at
30◦C and then serial dilutions plated onto low and high salt plates containing 100 gml−1 ampicillin and incubated at either 30◦C or 42◦C. (B) Suppression
of rep uvrD lethality by aspSP555S on rich medium was analysed by monitoring retention or loss of pRC7uvrD (pAM407) from the indicated strains at
30◦C on either low or high salt LB medium.
Figure 4. Ribosomal pausing decreases the requirement for accessory helicase activity. Retention or loss of pRC7rep (pAM403) was monitored at 37◦C on
LB X-gal IPTG plates for the indicated strains.
some containing a non-acylated tRNA in the A site (13,14).
Elevated (p)ppGpp is known to suppress rep uvrD invi-
ability (34) and so aspT[t8c] andefpmight both therefore
suppress via elevation of (p)ppGpp concentration.
Direct measurement of (p)ppGpp using 32P cannot be
performed on cells grown in rich media (79) which pre-
vents direct assessment of (p)ppGpp levels in aspT[t8c]
and efp strains under conditions relevant to suppression
of rep uvrD lethality. An indirect assay was therefore
used that employs an RpoS-mCherry translational fusion
(32). This reporter provides a fluorescence signal that cor-
relates with intracellular (p)ppGpp concentration due to
(p)ppGpp both stimulating rpoS transcription and inhibit-
ing RpoS degradation (32). Fluorescence was assayed by
flow cytometry of cells grown to mid-logarithmic phase in
rich medium. relA+ spoT+ cells lacking the RpoS–mCherry
fusion and rpoS-mCherry relA spoT cells which are un-
able to synthesize (p)ppGpp gave similar levels of back-
ground fluorescence (Figure 5Ai and ii). An increase in flu-
orescence was observed in wild type cells carrying the fu-
sion but this increase was modest (Figure 5A, compare iii
with i and ii), consonant with low (p)ppGpp levels in wild
type cells growing in nutrient-rich environments (32,80).
mCherry fluorescence increased substantially in efp cells
but not in aspT[t8c] cells with respect to wild type (Fig-
ure 5A, compare iv and v with iii). We conclude that ab-
sence of EF-P results in elevation of (p)ppGpp concentra-
tion. Higher (p)ppGpp concentration in efp cells as com-
paredwithwild type or aspT[t8c] cells is consistent with the
significant retardation of growth of efp cells (Figure 2A).
In contrast, aspT[t8c] either does not increase (p)ppGpp
levels as compared with wild type cells or any increase is
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Figure 5. (p)ppGpp synthesis is needed for suppression of rep uvrD lethality by aspT[t8c] and efp. (A) Flow cytometric detection of in vivo levels
of RpoS-mCherry fluorescence in the indicated strains. All strains contain the rpoS-mCherry fusion with the exception of (i) MG1655. (B) Survival after
challenge with ciprofloxacin. The strains are (i) TB28, (ii) KM241, (iii) N5777, (iv) KM231 and (v)MH372. (C) Retention and loss of pRC7uvrD (pAM407)
on LB X-gal IPTG agar in relA+ and relA strains.
below the limits of detection using this assay. To gauge the
sensitivity of this assay we monitored fluorescence in spoT1
cells. spoT1 encodes a SpoT enzyme that retains (p)ppGpp
synthase activity but lacks (p)ppGpp pyrophosphorylase
activity, resulting in elevated (p)ppGpp (81) and the ability
to suppressrepuvrD lethality (34). spoT1 rpoS-mCherry
cells did not result in increased fluorescence as compared
with spoT+ rpoS-mCherry cells indicating that (p)ppGpp
levels sufficient to reduce the need for accessory replicative
helicases could go undetected using this assay (Figure 5Aiii
and vi).
To address this potential sensitivity problem we em-
ployed a second assay to determine whether either efp or
aspT[t8c] results in elevated (p)ppGpp. Cells with elevated
(p)ppGpp display elevated levels of persistence and thus
spoT1 enhances whereasrelAspoT alleles reduce persis-
tence (32,82) (see also Figure 5Bi–iii). aspT[t8c] and efp
both increased persistence with the increase being higher for
efp (Figure 5Biv and v). The large increase in persistence
in efp cells correlates with the enhancement of fluores-
cence in efp rpoS-mCherry cells. The level of persistence
in aspT[t8c] cells is consistent with a smaller increase in
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(p)ppGpp levels as compared with efp that is below the
limits of detection in the mCherry fluorescence assay.
We tested whether increased (p)ppGpp contributed to
suppression of rep uvrD inviability by aspT[t8c] and
efp by deleting the gene encoding the primary (p)ppGpp
synthase, relA. Deletion of relA prevented loss of pRC7uvrD
from rep uvrD aspT[t8c] and rep uvrD efp cells,
indicating that RelA was required for suppression by both
mutant alleles (Figure 5C, compare iii with iv and v with
vi). In contrast, pRC7uvrD could be lost from rep uvrD
relA rpoB*35 cells indicating that RelA was not required
for the viability of suppressed repuvrD strains under all
circumstances (Figure 5C, compare vii and viii). This lack of
dependence of rep uvrD rpoB*35 on RelA likely reflects
the recapitulation by rpoB*35 of many phenotypes associ-
ated with elevated (p)ppGpp even in the absence of RelA
(48,66).
Taken together, these data indicate that RelA-directed
synthesis of (p)ppGpp is important for suppression of rep
uvrD lethality by both aspT[t8c] and efp.
aspT[t8c] and Δefp confer differing requirements for Rho
activity
Translocation 5′-3′ by Rho along untranslated and unstruc-
tured nascent transcripts can displace transcription com-
plexes thus reducing both RNA polymerase occupancy on
the chromosome and R-loop formation (9,83,84). Rep and
Rho therefore provide two different mechanisms that re-
duce the impact of transcription on replication. Conse-
quently, cells need either Rep or wild type levels of Rho ac-
tivity to maintain genome duplication in the face of tran-
scriptional barriers (8,85). One manifestation of this re-
quirement is the hypersensitivity of rep uvrD+ cells to low
concentrations of the Rho-specific inhibitor bicyclomycin
(8) (see also Figure 6A and B, compare i and iii).
We assessed whether efp or aspT[t8c] could sup-
press rep bicyclomycin hypersensitivity. Neither efp nor
aspT[t8c] altered bicyclomycin sensitivity in a rep+ back-
ground (Figure 6A and B, compare i and ii). In rep
cells hypersensitivity was suppressed by efp but not by
aspT[t8c] (Figure 6A andB, compare iii and iv). These data
demonstrate thatefp but not aspT[t8c] can reduce the re-
quirement for Rho activity in the absence of Rep.
We also tested whether this differential need for Rho
activity was reflected in cells lacking both rep and uvrD
by exploiting rho[A243E] which encodes a partial loss of
function enzyme (86). Rho dependency was assessed by
the ability of rep uvrD strains to lose a complement-
ing pRC7rep rather than pRC7uvrD plasmid, allowing con-
struction of pRC7rep/rep uvrD rho[A243E] strains re-
gardless of rep rho double mutant lethality (85). The similar
numbers and sizes of white plasmidless colonies formed by
repuvrD efp rho+ and rep uvrD efp rho[A243E]
cells indicate that wild type Rho function was not required
for suppression by efp (Figure 6C, compare v and vi). In
contrast, rep uvrD aspT[t8c] rho[A243E] gave much
smaller white plasmidless colonies as compared with the
isogenic rho+ strain indicating that wild type Rho function
was important for growth of aspT[t8c] rep uvrD cells
(Figure 6C, compare iii and iv).
The data in Figures 5 and 6 indicate that the viability
of aspT[t8c] rep uvrD cells requires both the major
(p)ppGpp synthase in the cell, RelA, and wild type Rho
activity. In contrast, efp rep uvrD cells require RelA
but not wild type Rho activity. efp cells have higher lev-
els of (p)ppGpp as compared with aspT[t8c] (Figure 5A)
and these elevated levels might explain the differential re-
quirement for Rho, given the ability of (p)ppGpp to re-
duce replication/transcription conflicts (10,34,66). Such a
model implies that (p)ppGpp synthesis is critical not only
for the viability of efp rep uvrD cells (Figure 5C) but
also for suppression of bicyclomycin sensitivity ofrep cells
(Figure 6A). Absence of the primary (p)ppGpp synthase
RelA did not hypersensitize otherwise wild type cells to
bicyclomycin (Figure 7Aiii). However, the suppression of
rep bicyclomycin hypersensitivity by efp was abolished
upon deletion of relA (Figure 7A, compare viii with v). Thus
RelA-dependent (p)ppGpp synthesis in rep efp cells is
essential for survival with lowered Rho activity, supporting
the hypothesis that elevated (p)ppGpp can reduce the need
for Rho.
We tested this possible link between (p)ppGpp concen-
tration and requirement for Rho by analysing the impact of
other means of increasing (p)ppGpp concentration onrep
bicyclomycin hypersensitivity. The spoT1 allele suppressed
rep bicyclomycin hypersensitivity supporting the conclu-
sion that elevated (p)ppGpp can reduce the need for Rho
(Figure 7B, compare iv with ii).
The data in Figures 5–7 indicate that both aspT[t8c] and
efp require RelA-directed synthesis of (p)ppGpp to main-
tain the viability of repuvrD cells. In contrast, efp has
amuch lower dependence onRho activity as comparedwith
aspT[t8c]. This differential requirement for Rho activity
correlates with higher (p)ppGpp levels in efp cells as com-
pared with aspT[t8c]. Resolving conflicts between repli-
cation and transcription involves therefore a fine balance
between accessory replicative helicases, levels of (p)ppGpp
and Rho activity.
DISCUSSION
We have discovered three new types of suppressors of rep
uvrD rich medium lethality: mutations in tRNA genes,
in aminoacyl-tRNA synthetases and in translation elonga-
tion factors. Whilst the mechanistic consequences of the
aspT[t8c] mutation are unclear, the inhibition of tRNA
aminoacylation by aspSP555S and of translation elonga-
tion by efp are well-characterized (56,74,75), indicating
that partial inhibition of translation can suppress rep
uvrD lethality. Previous studies have demonstrated that
this lethality is caused primarily by the conflict between
replication and transcription (20,34,54). Thus partial in-
hibition of translation can compensate for the impact of
transcription on DNA replication in the absence of Rep
and UvrD. Suppression requires RelA-directed synthesis of
(p)ppGpp with (p)ppGpp concentration being higher with
efp than with aspT[t8c] (Figure 5). Wild type levels of
Rho activity are also needed in aspT[t8c] rep uvrD but
not efp rep uvrD cells indicating that the relative im-
portance of (p)ppGpp and Rho function depends upon the
nature of the translational mutation (Figure 6).
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Figure 6. efp but not aspT[t8c] can bypass the need for wild type Rho activity. (A) and (B) The indicated strains were grown in liquid culture in the
absence of bicyclomycin and their ability to continue to divide with reduced Rho activity was assessed after serial dilution onto plates without and with 25
g ml−1 bicyclomycin. (C) Loss of pRC7rep (pAM403) on LB X-gal IPTG agar in rho+ (i, iii, v) and rho[A243E] (ii, iv, vi) strains.
rep uvrD cells are inviable on rich medium primar-
ily because of lack of accessory replicative helicase func-
tion (20,34,54). Suppression of this growth defect by the
above translation mutations (Figures 1A, 3B and 4) there-
fore suggest that it is the lack of accessory helicase activity
in rep uvrD cells that is being suppressed. Suppression
by aspT[t8c] of the chromosome content defect of rep
cells, a direct consequence of slower fork movement in the
absence of Rep accessory helicase activity (34,38,39), sup-
ports this view (Figure 1B). UvrD also inhibits RecFOR-
dependent loading of RecA at blocked replication forks
(52,68) and absence of this function makes a minor con-
tribution to rep uvrD lethality (20,34,53). However, the
lack of suppression of this RecA displacement defect by
aspT[t8c] (Supplementary Figure S1C) indicates that sup-
pression ofrepuvrD lethality by aspT[t8c] does not op-
erate via an effect on RecA loading. UvrD might also aid
replication of transcribed DNA by inducing backtracking
of RNAP stalled at DNA lesions, one consequence of which
may be to promote repair of the lesion and allow the RNAP
to then continue transcription (12). However, rep uvrA
cells, lacking nucleotide excision repair, are viable (54) indi-
cating that lesion repair via UvrD-catalysed backtracking
of RNAP cannot be a major contributor to rep uvrD
lethality. aspT[t8c] also does not suppress the sensitivity of
uvrD cells to UV light indicating that aspT[t8c] does not
suppress nucleotide excision repair defects (Supplementary
Figure S1A). Furthermore, aspT[t8c] suppression of the
greA greB growth defect indicates that aspT[t8c] can
suppress the absence of an anti-backtracking activity, mak-
ing it difficult to explain how aspT[t8c] could also suppress
the absence of a UvrD pro-backtracking function (Figure
1C).
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Figure 7. The ability of efp to bypass the requirement for wild type Rho
activity is dependent on (p)ppGpp synthesis. (A) and (B) Strains were
grown in the absence of bicyclomycin and then serial dilutions were plated
onto LB agar without and with 25 g ml−1 bicyclomycin.
RelA-directed synthesis of (p)ppGpp plays a central role
in maintaining rep uvrD viability by aspT[t8c] and by
efp (Figure 5C). (p)ppGpp dramatically inhibits tran-
scription of rrn operons (17) which are the primary tran-
scriptional barriers to genome duplication (19,22), together
with other highly expressed operons (18). (p)ppGpp may
also destabilize stalled RNAP (10) or increase the fidelity of
transcription (23), both of which could decrease the impact
of transcription on fork movement. aspT[t8c]- and efp-
directed suppression of repuvrD lethality via (p)ppGpp
is therefore likely to occur by impacting on transcription
initiation, stalled RNAP stability and/or decreased pausing
due to enhanced fidelity.
RelA is stimulated to synthesize (p)ppGpp when an un-
charged cognate tRNA is bound to the ribosomal A site
(13,14). aspT[t8c] and efp mutations may therefore in-
crease the probability of A site-bound uncharged tRNA ei-
ther directly or indirectly. The uridine at position 8 is highly
conserved in tRNA species and the equivalent t8cmutation
within human mitochondrial tRNAMet results in inhibition
of tRNA aminoacylation (70). If aspT[t8c] also resulted in
inhibition of aminoacylation then the resulting increase in
non-acylated tRNAAsp could lead to an increased probabil-
ity of uncharged tRNAAsp occupying the ribosomal A site.
However, whether the mutant tRNAAsp can still bind to the
A site is unknown. Alternatively tRNAasp[t8c] might poison
the aspartyl tRNA synthetase by binding to it and forming
a dead end complexwith respect to aminoacylation. Forma-
tion of such a dead end complex might titrate out aspartyl
tRNA synthetase and increase levels of uncharged wild type
tRNAAsp leading to increased non-acylated tRNAAsp occu-
pying the ribosomal A site. For cells lacking EF-P, YjeA or
YjeK it is difficult to conceive howa reduced rate of proline–
proline bond formation within the ribosome could lead di-
rectly to increased occupancy of the A site by uncharged
tRNA. Absence of any one of these three factors, though,
does impact on expression of many genes and so altered ex-
pression of one ormore genes inefp,yjeA oryjeK cells
could result in an increased probability of A site-bound un-
charged tRNA. For example, efp cells have reduced ex-
pression of valyl tRNA synthetase (87) which could lead to
accumulation of uncharged tRNAVal and triggering of the
stringent response. Suppression of repuvrD lethality by
aspSP555S demonstrates that suppression via partial loss of
tRNA synthetase function can occur (Figure 3).
In contrast to the requirement for RelA to sustain
suppression of rep uvrD lethality by both aspT[t8c]
and efp, the requirement for Rho activity is reduced in
efp as compared with aspT[t8c] cells (Figures 6 and 7).
This difference correlates with the higher concentration of
(p)ppGpp in efp as compared with aspT[t8c] cells (Fig-
ure 5). A role for (p)ppGpp in reducing the need for Rho
activity is supported by the ability of spoT1 to suppress
rep bicyclomycin hypersensitivity (Figure 7B). Suppres-
sion of rep bicyclomycin hypersensitivity by efp also de-
pends on RelA which supports a critical balance between
(p)ppGpp concentration and Rho activity in maintaining
viability (Figure 7A). Elevated (p)ppGpp can therefore re-
duce the need for Rho.
The greater dependence of aspT[t8c]-directed suppres-
sion on Rho might reflect not just lower (p)ppGpp levels in
aspT[t8c] versus efp cells but possibly also enhancement
of Rho binding on nascent transcripts by aspT[t8c]. In
other words, suppression via aspT[t8c]might occur at least
partly via the increased generation of Rho binding sites on
emerging transcripts. Aspartate codons are more frequent
than polyproline tracts and hence aspT[t8c] has the poten-
tial to impact on ribosome translocation more frequently
than efp. Enhancement of Rho binding would also be de-
pendent only on ribosomal pausing and not specifically re-
quire ribosomal A site occupancy by a non-aminoacylated
tRNA (88), in contrast to stimulation of RelA activity
(13,14). However, any aspT[t8c]-directed increase of tran-
scription complex displacement byRho cannot be sufficient
by itself to suppress repuvrD lethality since RelA is also
needed (Figure 5C).
Our data indicate that whilst translation helps prevent
RNAP backtracking (5,7) the reduction of conflicts be-
tween replication and transcription can be achieved more
effectively by partial inhibition of translation. Of course,
the growth defect in efp cells (Figure 2A) indicates why
the balance between replication, transcription, translation
and (p)ppGpp synthesis is poised as it is in wild type cells.
Thus for the maintenance of rapid growth there is a very
fine balance to be struck between gene expression and ac-
curate, rapid genome duplication. Furthermore, accessory
replicative helicases play a major role in determining this
balance. In the absence of both Rep and UvrD the wild
type balance between various other mechanisms that re-
duce the impact of transcription on replication is unable
to effectively counter the adverse effects of transcription on
completion of genome duplication. There may also be cir-
cumstances under which mutations such as those identified
here confer a selective advantage even in rep+ uvrD+ cells.
Elevated (p)ppGpp is a key factor in determining bacterial
persistence in the face of antibiotic challenge (32) and both
aspT[t8c] and efp mutations enhance persistence (Fig-
ure 5B). It remains possible therefore that mutations such
as aspT[t8c] that have only a modest inhibitory effect on
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growth could arise in bacterial populations continually ex-
posed to antibiotics, especially given the many mutations
known to affect translation (89). Increased persistence in
strains lacking EF-P function also imply that EF-P and its
unique post-translational modification pathway are poor
potential targets for antibiotics.
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